1.410CAD-0.70%Mkt Cap: 413.72M CADP/E: —Last update: 2026-06-01
Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activi…
Industry Peers
Diagnostics & Research183.26BUSDP/E 27.1
127.46BUSDP/E 35.0
45.09BUSDP/E 42.1
38.48BUSDP/E 27.4
37.00BUSDP/E 47.9
34.66BCHFP/E 38.1
31.51BUSD—
31.45BUSDP/E 23.4
Indicators:|
Key Statistics
Company
Market Cap413.72M CAD
Enterprise Value437.44M CAD
Revenue (TTM)2.76M CAD
Gross Profit1.33M CAD
Net Income (TTM)-47.69M CAD
Revenue/Share0.0100 CAD
Last Price1.410 CAD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees29
CountryCA
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)Infinity
PEG—
EV/EBITDA-41.03
EV/Revenue158.44
P/S150.91
P/B-5.89
EPS (TTM)-0.13
EPS (Forward)0.00
52W Range
0.770060% of range1.840
52W High1.840 CAD
52W Low0.7700 CAD
Profitability
Gross Margin54.30%
Oper. Margin-362.51%
EBITDA Margin0.00%
Profit Margin-1952.99%
ROE68.40%
ROA-781.84%
Growth
Revenue Growth55.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.52M CAD
CapEx (TTM)195.00K CAD
FCF Margin625.33%
FCF Yield4.17%
Net Debt21.05M CAD
Net Debt/EBITDA-1.97
Balance Sheet
Debt/Equity-0.31
Current Ratio0.06
Quick Ratio0.04
Book Value/Sh-0.2410 CAD
Cash/Share0.0070 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateDec 19, 2011
Pay Date—
Analyst Consensus
Rating—
Target (Mean)3.150 CAD
Target Range2.800 CAD – 3.500 CAD
# Analysts2
Ownership
Shares Out.293.42M
Float288.39M
Insiders17.08%
Institutions12.44%
Short Interest
Short Ratio6.9d
Short % Out.0.11%
Shares Short313.75K
Short (prev mo.)313.21K
Technical
SMA 501.391 (+1.4%)
SMA 2001.388 (+1.6%)
Beta—
S&P 52W Chg27.70%
Avg Vol (30d)55.18K
Avg Vol (10d)66.15K
Technical Indicators
RSI (14)54.2
MACD0.0091
MACD Signal0.0081
MACD Hist.+0.0010
BB Upper1.449 CAD
BB Middle1.403 CAD
BB Lower1.356 CAD
BB Width6.66%
ATR (14)0.0498 CAD
Vol Ratio (20d)1.43x